These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6427848)

  • 1. Pharmacokinetics of lithium preparations in patients.
    Johnson GF; Hunt GE
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):63-70. PubMed ID: 6427848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of standard (lithicarb) and sustained-release (Priadel) lithium carbonate preparations in patients.
    Johnson GF; Hunt GE; Lewis J; St George B
    Aust N Z J Psychiatry; 1982 Mar; 16(1):64-8. PubMed ID: 6810866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of lithium carbonate and lithium citrate: a comparison of two controlled-release preparations.
    Tyrer SP; Peat MA; Minty PS; Luchini A; Glud V; Amdisen A
    Pharmatherapeutica; 1982; 3(4):243-6. PubMed ID: 6815664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single dose pharmacokinetics of 5 formulations of lithium: a controlled comparison in healthy subjects.
    Shelley RK; Silverstone T
    Int Clin Psychopharmacol; 1986 Oct; 1(4):324-31. PubMed ID: 3104448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of ordinary and sustained-release lithium carbonate in manic patients after acute dosage.
    Thornhill DP
    Eur J Clin Pharmacol; 1978 Dec; 14(4):267-71. PubMed ID: 365541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels and pharmacokinetics of ordinary and sustained-release lithium carbonate in manic patients during chronic dosage.
    Thornhill DP
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):257-61. PubMed ID: 3089950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of standard and sustained-release (Priadel) lithium carbonate preparations.
    Johnson G; Hunt G; Jackson D; Richards T; Kwan E
    Med J Aust; 1979 Oct; 2(7):382. PubMed ID: 390347
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspect of the pharmacokinetics of slow-release lithium carbonate.
    Hart GA
    S Afr Med J; 1984 Aug; 66(5):178-9. PubMed ID: 6431618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of standard and slow-release oral lithium carbonate products.
    Wallis J; Miller R; McFadyen ML; Carlile JB
    S Afr Med J; 1989 Dec; 76(11):618-20. PubMed ID: 2512655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption of lithium following administration of slow-release and conventional preparations.
    Tyrer S; Hullin RP; Birch NJ; Goodwin JC
    Psychol Med; 1976 Feb; 6(1):51-8. PubMed ID: 935297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations.
    Arancibia A; Corvalan F; Mella F; Concha L
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):240-5. PubMed ID: 3089949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steady-state lithium blood level fluctuations in man following administration of a lithium carbonate conventional and controlled-release dosage form.
    Caldwell HC; Westlake WJ; Schriver RC; Bumbier EE
    J Clin Pharmacol; 1981; 21(2):106-9. PubMed ID: 6785324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single dose pharmacokinetics of a controlled release lithium preparation "Liskonum" in African patients suffering from manic depressive psychosis.
    Mengech HN; Ojwang PJ
    East Afr Med J; 1984 Apr; 61(4):321-5. PubMed ID: 6489236
    [No Abstract]   [Full Text] [Related]  

  • 14. [Slow-release lithium carbonate versus standard preparation in bipolar affective disorders (author's transl)].
    Bohacek N; Mihovilović M
    Lijec Vjesn; 1980 Oct; 102(10):575-9. PubMed ID: 6790888
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum concentrations of lithium after three proprietary preparations of lithium carbonate (Priadel, Phasal and Camcolit).
    Bennie EH; Manzoor AK; Scott AM; Fell GS
    Br J Clin Pharmacol; 1977 Aug; 4(4):479-83. PubMed ID: 901741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium: updated human knowledge using an evidence-based approach. Part II: Clinical pharmacology and therapeutic monitoring.
    Grandjean EM; Aubry JM
    CNS Drugs; 2009; 23(4):331-49. PubMed ID: 19374461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel slow-release formulation of lithium carbonate (Carbolithium Once-A-Day) vs. standard Carbolithium: a comparative pharmacokinetic study.
    Castrogiovanni P
    Clin Ter; 2002; 153(2):107-15. PubMed ID: 12078335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and in vitro-in vivo evaluation of sustained-release lithium carbonate tablets.
    Ciftçi K; Capan Y; Oztürk O; Hincal AA
    Pharm Res; 1990 Apr; 7(4):359-63. PubMed ID: 2114020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium absorption: implications for sustained-release lithium preparations.
    Ehrlich BE; Diamond JM
    Lancet; 1983 Feb; 1(8319):306. PubMed ID: 6130326
    [No Abstract]   [Full Text] [Related]  

  • 20. The single-dose bioavailability of different lithium carbonate products.
    Tsang HY; Chen CC; Wen JK
    Taiwan Yi Xue Hui Za Zhi; 1987 May; 86(5):543-8. PubMed ID: 3114414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.